Arcadia Biosciences Inc. is a producer and marketer of plant-based health and wellness products. Arcadia Biosciences Inc. is based in DALLAS.
| Revenue (Most Recent Fiscal Year) | $5.05M |
| Net Income (Most Recent Fiscal Year) | $-7.04M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.97 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.16 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -130.77% |
| Net Margin (Trailing 12 Months) | -139.36% |
| Return on Equity (Trailing 12 Months) | -34.75% |
| Return on Assets (Trailing 12 Months) | -20.91% |
| Current Ratio (Most Recent Fiscal Quarter) | 4.12 |
| Quick Ratio (Most Recent Fiscal Quarter) | 3.31 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 2.98 |
| Book Value per Share (Most Recent Fiscal Quarter) | $3.32 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NASDAQ |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Common Shares Outstanding | 1.37M |
| Free Float | 1.34M |
| Market Capitalization | $5.26M |
| Average Volume (Last 20 Days) | 4868.00 |
| Beta (Past 60 Months) | 0.51 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.80% |
| Percentage Held By Institutions (Latest 13F Reports) | 17.73% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |